We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.60 | 7.59 | 7.68 | 7.69 | 7.59 | 7.66 | 2,551,609 | 21:30:14 |
From May 2021 to May 2024
By Jacob Bunge
Bayer AG welcomed its victory in the most recent trial considering a claim that its Roundup herbicide caused cancer, but hopes a ruling by the U.S. Supreme Court in a separate case will help put to rest yearslong litigation over the weedkiller.
Bayer in August filed a petition asking the top U.S. court to nullify an earlier federal court decision in favor of a plaintiff making similar allegations. Bayer argued that the company could not have warned of any cancer risk posed by Roundup because U.S. federal regulators had deemed it safe following multiple reviews.
Bayer has maintained that research shows the weedkiller does not cause cancer, and anticipates the Supreme Court will decide in the next few months whether to take up the matter.
A win at the Supreme Court, Bayer has said, could affect thousands of other Roundup cases the company faces.
Write to Jacob Bunge at jacob.bunge@wsj.com
(END) Dow Jones Newswires
October 05, 2021 20:30 ET (00:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
